Dr Yasuhiro Takagi

Head of Modality Technology, Chemical & Biological Technology Labs. at Astellas Pharma Inc., Japan

Speaker

Dr. Yasuhiro Takagi, Head of Modality Technology, CMC development at Astellas Pharma Inc. is a seasoned professional with a Ph.D. in Biotechnology and over 15 years of industry experience. His expertise lies in CMC, with a focus on cell line development, process development for biologics, and manufacturing process development for cell therapy. With a strong track record in leading cross-functional teams, Yasuhiro Takagi has successfully managed various aspects of CMC development, technology transfer, GMP manufacturing, and regulatory interactions with agencies.